Panel just says no to opioid REMS; Drugs welcome at PA community night out;

> An FDA panel has turned in a thumbs-down vote on a proposal intended to curb misuse of long-acting narcotics for pain, finding it falls short by making physician training voluntary. Article

> Franklin County, PA, is adding a link to the pharma supply chain next week by holding its first medication take-back program--for unwanted and expired drugs--during the community's National Night Out. Story

> Therapure Biopharma will provide fill/finish services to support development of OPK Biotech's drug used to increase oxygen transport. Release

> NextPharma has added a bottle filling line for tablets at its Göttingen, Germany, facility for dry dosage forms. Announcement

> U.S. Marshals have seized $39,000 in cyanide antidote kits from Keystone Pharmaceuticals in Laguna Hills, CA. Announcement

Suggested Articles

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.